SG Capital Management LLC Sells 47,620 Shares of Adtalem Global Education Inc. $ATGE
SG Capital Management LLC reduced its stake in Adtalem Global Education Inc. by 38.5%, selling 47,620 shares and retaining 76,056 shares valued at $11.75 million, which now represents 1.0% of its portfolio. Adtalem reported a strong quarter with EPS of $2.43 against an expected $2.19 and revenue of $503.4 million, also providing optimistic FY2026 EPS guidance. The stock holds a "Moderate Buy" consensus rating with a $151.50 average target price, despite mixed recent analyst actions including a downgrade by Weiss and positive notes from BMO, Baird, and Barrington.
Covista Name Change Puts Focus On Governance And Future Priorities
Adtalem Global Education Inc. (NYSE:ATGE) has officially changed its corporate name to Covista Inc., with the rebranding reflected in updated corporate documents. This move is presented as an administrative decision by the board, rather than an immediate shift in strategy or leadership. Investors are advised to monitor future communications for insights into Covista's priorities and how the new identity aligns with its long-term objectives in the evolving education sector.
New Ross Med dean will lead school graduating most U.S. M.D.s
Covista (NYSE: ATGE) has appointed Cheryl Holmes, M.D., as the new dean of Ross University School of Medicine (RUSM), effective March 16. Dr. Holmes brings over 30 years of clinical and academic leadership experience, and her appointment aims to strengthen RUSM's role in addressing the healthcare workforce shortage. RUSM is noted for graduating more M.D.s than any other U.S. medical school and achieving a 96% first-time residency attainment rate for its 2024-2025 graduates.
Covista Name Change Puts Focus On Governance And Future Priorities
Adtalem Global Education Inc. has officially changed its corporate name to Covista Inc. (NYSE:ATGE), a move formalized through amendments to corporate documents. While this rebranding primarily signifies an administrative update in governance, it also presents an opportunity for the company to articulate new priorities and strategies in the evolving education sector. Investors are advised to monitor future communications for insights into how this new identity aligns with Covista's strategic direction and capital allocation plans.
Why Adtalem Global Education (ATGE) is a Top Value Stock for the Long-Term
This article highlights Adtalem Global Education (ATGE) as a top value stock for long-term investment. It suggests that interested investors can access further recommendations and free stock analysis from Zacks Investment Research. The content was originally published on Zacks.com.
Is Covista’s (ATGE) Rebrand the Missing Link in Its Healthcare Education Competitive Edge?
Covista Inc., formerly Adtalem Global Education Inc., has rebranded to focus on healthcare education, including AI credentials and workforce support, to address staffing gaps. The rebranding underlines a shift to a singular healthcare identity, with a partnership with Google Cloud for AI credentials being a significant component of its investment narrative. While the rebranding is largely cosmetic, the company's focus on healthcare and execution on enrollment, margins, and buyback authorization, along with managing regulatory risks, remain key factors for its investment appeal.
Public Sector Pension Investment Board Boosts Stock Holdings in Adtalem Global Education Inc. $ATGE
The Public Sector Pension Investment Board increased its stake in Adtalem Global Education (NYSE:ATGE) by 11.8% in Q3, now owning 157,012 shares valued at $24.25 million. Analysts have provided mixed signals; while Zacks upgraded long-term EPS forecasts, some near-term estimates were trimmed, and the stock was labeled oversold. Adtalem recently surpassed quarterly earnings and revenue expectations and provided strong FY2026 guidance.
Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround
Adtalem Global Education (ATGE) has experienced a significant 20.9% decline in its stock price over the past month. However, the stock now appears oversold with an RSI reading of 29.18, suggesting a potential for reversal. This technical indicator, combined with rising earnings estimates from analysts and a Zacks Rank #2 (Buy), indicates that ATGE could be poised for a near-term turnaround.
LSV Asset Management Lowers Stake in Adtalem Global Education Inc. $ATGE
LSV Asset Management has reduced its stake in Adtalem Global Education Inc. (NYSE:ATGE) by 5.8% in the third quarter of 2025, selling 32,200 shares and now owning 521,800 shares valued at approximately $80.59 million. Despite this, Adtalem Global Education has shown strong financial performance, beating earnings and revenue estimates in its latest quarter and providing a positive EPS guidance for FY2026. Analysts currently hold a "Moderate Buy" consensus rating for the company with an average price target of $151.50.
Cibc World Market Inc. Purchases 27,297 Shares of Adtalem Global Education Inc. $ATGE
Cibc World Market Inc. increased its holdings in Adtalem Global Education Inc. by 28% in the third quarter, acquiring an additional 27,297 shares, bringing its total ownership to 124,867 shares valued at $19.29 million. Other institutional investors like Allspring Global Investments and Goldman Sachs also significantly boosted their stakes. Adtalem Global Education recently beat quarterly earnings expectations with $2.43 EPS and $503.39 million in revenue, and has provided strong FY2026 EPS guidance.
Candriam S.C.A. Sells 58,465 Shares of Adtalem Global Education Inc. $ATGE
Candriam S.C.A. significantly reduced its stake in Adtalem Global Education (ATGE) by 92.9% in Q3, selling 58,465 shares, though other major institutional investors like Allspring and Goldman Sachs increased their holdings. Adtalem Global Education reported strong Q3 earnings, exceeding EPS and revenue expectations, and provided optimistic FY2026 guidance. The stock currently holds a "Moderate Buy" analyst rating with an average target price of $151.50.
(ATGE) Volatility Zones as Tactical Triggers
This article provides an in-depth analysis of Adtalem Global Education Inc. (NASDAQ: ATGE) using AI models to determine tactical triggers and trading strategies. It highlights weak near and mid-term sentiment, a neutral long-term outlook, and presents position trading, momentum breakout, and risk hedging strategies with specific entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal analysis indicating support and resistance levels.
Adtalem Global Education Stock To $124?
Adtalem Global Education (ATGE) stock has recently dropped by 21.8%, but Trefis believes it has a strong chance of rebounding to $124 due to its history of recovery post-dips and its passing of basic financial quality checks. Historically, the stock has shown a median return of 61% within 12 months after similar sharp dips, with a median peak return of 70%. The company demonstrates robust revenue growth, profitability, and a strong balance sheet, suggesting that the current dip may present a buying opportunity.
Covista Reinvents Healthcare Education Amid Workforce Shortage
Covista, formerly Adtalem Global Education, is strategically addressing the severe U.S. healthcare workforce shortage by focusing solely on healthcare education, graduating 24,000 students annually. The company has also partnered with Google Cloud to launch an AI credentials program and is investing in initiatives to support healthcare workers' mental health and career development. Despite policy challenges, Covista remains optimistic about attracting more students due to the high demand for healthcare professionals.
How the largest health-care education company in U.S. is addressing a growing jobs gap
Covista, formerly Adtalem Global Education, is strategically focusing on healthcare education to tackle a significant worker shortage in the U.S. healthcare industry. With over 8.4 million open healthcare jobs, Covista provides a substantial number of graduates annually, including 10% of America's nurses and twice as many MDs as any other institution. The company's rebranding to Covista reflects its commitment to addressing this growing workforce gap, which CEO Steve Beard warns could lead to a "patient care crisis."
How the largest health-care education company in U.S. is addressing a growing jobs gap
Covista (formerly Adtalem Global Education), the largest health-care education company in the U.S., is focusing on addressing a significant worker shortage in the health-care industry. With over 8.4 million open health-care jobs, Covista aims to provide day-one-ready talent and innovate solutions through partnerships and AI programs. Despite challenges like federal student loan changes, the company remains optimistic about meeting the needs of an aging population.
Covista Rebrand Highlights Healthcare Focus Ahead Of Investor Day Plans
Adtalem Global Education Inc. has rebranded as Covista Inc. (NYSE:ATGE), signaling a strategic focus on career-connected healthcare education. This rebrand follows a four-year transformation and aligns the company with the growing demand for healthcare professionals. An upcoming Investor Day will provide further details on Covista's future strategy, capital allocation, and positioning within the healthcare education segment.
Adtalem Global Education's (NYSE:ATGE) Five-year Earnings Growth Trails the 21% YoY Shareholder Returns
Adtalem Global Education (NYSE:ATGE) has seen its share price increase by 163% over the last five years, translating to a 21% annual return for shareholders. However, the company's earnings per share (EPS) grew at a slower rate of 7.5% per year during the same period, suggesting an increased market valuation for the company. Despite a recent 9.6% decline in the last month, the long-term share price performance indicates positive market perception, further supported by insider purchases.
A Look At Adtalem Global Education’s Valuation As It Rebrands To Covista And Highlights Healthcare Focus
Adtalem Global Education (ATGE) is rebranding to Covista, emphasizing a healthcare focus, and analysts believe the stock is undervalued. The company's P/E ratio of 14.2x is below industry averages, and discounted cash flow models suggest a significant undervaluation relative to its estimated fair value of $234.25 per share. Despite mixed recent trading, its strong historical shareholder return and solid earnings suggest potential for growth.
Adtalem Global Education Inc (NYSE:ATGE) Presents a Compelling Value Investment Case
Adtalem Global Education Inc (NYSE:ATGE) is presented as a compelling value investment due to its attractive valuation, solid financial condition, strong earnings, and reasonable expansion prospects. The company's low Price-to-Earnings ratio, robust solvency, high return on invested capital, and projected EPS growth suggest it is undervalued by the market. While investors should consider industry-specific risks, ATGE aligns with key value investing principles, offering a margin of safety.
Will Strong Earnings, Covista Rebrand and Buybacks Change Adtalem Global Education's (ATGE) Narrative?
Adtalem Global Education, soon to be Covista, reported strong quarterly earnings, reiterated its fiscal 2026 revenue outlook, and continued share repurchases. The rebrand signals a focus on healthcare education to address workforce needs, aiming to reshape its investment narrative. While the company reinforces a profitable and capital-disciplined story, investors should consider potential risks like rising capital intensity and its impact on margins and valuation.
Largest US healthcare educator unveils new name, expanded mission
Adtalem Global Education, the largest healthcare educator in the U.S., has rebranded itself as Covista, signifying an expansion of its mission. This change was announced on February 5, 2026, and was reported by Jon Asplund of Crain's Chicago Business. The article briefly mentions other featured stories related to healthcare politics, insurance, and medical devices.
Largest health care educator in the U.S. unveils new name, expanded mission
Adtalem Global Education, the largest health care educator in the U.S., has rebranded as Covista, marking a significant step in its transformation into a multi-university network focused on the health care workforce. Covista plans to expand its health care career network and address the critical workforce shortages, especially in nursing and behavioral health, through organic growth, acquisitions, and new research initiatives. The company currently educates nearly 100,000 students and contributes significantly to the health care workforce annually.
Adtalem Global Education Becomes Covista
Adtalem Global Education has rebranded to Covista, signifying its transformation into America's largest healthcare educator focused on addressing the U.S. healthcare workforce crisis. The company, which will trade under the ticker CVSA starting February 24, 2026, also released new research on the healthcare staffing gap and launched "Covista Open Doors," a multi-year initiative to support healthcare career pathways. Covista will discuss its long-term strategy at an Investor Day on February 24.
The Top 5 Analyst Questions From Adtalem's Q4 Earnings Call
Adtalem Global Education (ATGE) reported strong Q4 results with significant enrollment gains at Walden University and Chamberlain, exceeding analyst estimates for revenue, EPS, and EBITDA. The article highlights key analyst questions regarding market share, preparedness for loan cap changes, and enrollment improvement timelines, and discusses future catalysts like new program launches and the Sallie Mae partnership. Despite the positive earnings, the stock saw a dip, prompting a call for investors to evaluate its current buy/sell status.
Earnings call transcript: Adtalem’s Q2 2026 earnings beat expectations
Adtalem Global Education (NYSE:ATGE) exceeded Q2 2026 earnings expectations with an EPS of $2.43 and revenue of $503.4 million, marking a 10.96% surprise in EPS and a 12.4% year-over-year revenue increase. The company raised its full-year adjusted EPS guidance and reported its 10th consecutive quarter of enrollment growth, reaching 97,000 students. Despite these strong financial results, the stock experienced a 6.46% decline in after-hours trading.
3 School Stocks Leveraging AI & Healthcare Demand Amid Headwinds
The Zacks Schools industry faces challenges like a shrinking student base and regulatory oversight but is seeing improved medium-term prospects due to demand for career-oriented education in healthcare and IT. Technology adoption and industry consolidation are key differentiators, with Workforce Pell expansion also supporting enrollment. Three stocks highlighted for growth potential include American Public Education (APEI), Adtalem Global Education (ATGE), and Stride (LRN), all leveraging these trends.
Assessing Adtalem Global Education (ATGE) Valuation After Recent Share Price Pullback
Adtalem Global Education (ATGE) has experienced a recent share price pullback, declining 4% in a day and 12% over the past week, despite strong long-term returns. The company appears undervalued with a P/E ratio of 14.1x compared to peers and an estimated fair P/E of 19.1x, and its shares are trading at a significant discount according to a discounted cash flow model. This analysis suggests ATGE might be a genuine opportunity rather than a market pricing in future growth, though potential shifts in healthcare education demand need consideration.
Adtalem Weighs Enrollment Momentum And Buybacks Against Recent Share Weakness
Adtalem Global Education (NYSE:ATGE) has reported its tenth consecutive quarter of student enrollment growth and authorized a new $750 million share buyback after completing a previous $150 million program. While the company is expanding health system partnerships and integrating AI into its programs, its share price has declined by 14.6% in the past week and 3.3% in the past year, prompting investors to assess current operations against recent market moves. The stock is currently trading significantly below analyst targets and estimated fair value, suggesting potential for closer examination by investors.
Adtalem Global Education Inc (ATGE) Q2 2026 Earnings Call Transcript
Adtalem Global Education Inc. reported its Q2 2026 earnings, marking its 10th consecutive quarter of enrollment growth and raising its adjusted earnings per share guidance to 17-20% growth. The company achieved record enrollments at Walden and Chamberlain, with overall revenue up 12% to $503 million and adjusted EPS increasing 34% to $2.43. Leadership discussed strategies for addressing the healthcare workforce shortage and confirmed their full-year revenue guidance while updating EPS expectations.
Adtalem Global Education Inc (ATGE) Q2 2026 Earnings Call Transcript
Adtalem Global Education Inc. (ATGE) reported its Q2 2026 earnings, marking its 10th consecutive quarter of enrollment growth. The company reaffirmed its full-year revenue guidance of 6% to 8.5% growth and raised its adjusted EPS guidance to 17% to 20% growth, driven by strong performance at Walden and MedVet, despite a temporary pause in enrollment growth at Chamberlain. Leadership also previewed an upcoming Investor Day to discuss multi-year growth frameworks and capacity expansion plans.
Adtalem Global Education (ATGE) Margin Strength In Q2 2026 Reinforces Bullish Valuation Narratives
Adtalem Global Education (ATGE) reported its Q2 2026 results with revenue of US$503.4 million and EPS of US$2.13, showing strong net profit margins at 13.4%, up from 12.1% a year prior. While earnings growth is fueled by margins and efficiency, revenue growth forecasts (6% annually) and overall earnings growth (13% annually) lag behind the broader US market expectations. Despite this, the stock's current P/E of 14.6x is below peer and sector averages, and its DCF fair value suggests significant undervaluation, presenting a bullish case driven by earnings power rather than rapid top-line expansion.
Adtalem Q4 FY2025 Results: Revenue Tops Estimates, EPS Guidance Raised - News and Statistics
Adtalem Global Education reported strong Q4 FY2025 results, exceeding revenue expectations with sales up 12.4% year over year to $503.4 million. The company also surpassed analyst estimates for non-GAAP profit per share and raised its full-year Adjusted EPS guidance to $7.90. Adtalem, a major healthcare educator, highlighted its 10th consecutive quarter of enrollment growth, addressing healthcare workforce gaps.
Adtalem Q2 FY2026 Results: $76.4M Profit, $2.43 Adjusted EPS - News and Statistics
Adtalem Global Education Inc. (ATGE) reported a fiscal second-quarter net income of $76.4 million, with an adjusted earnings per share of $2.43. The company's revenue for the period reached $503.4 million. Adtalem shares have seen a 12% increase since the beginning of the year and an 18% increase over the last 12 months, closing at $115.92.
ATGE Q4 Deep Dive: Enrollment Expansion and Digital Investments Drive Guidance Upside
Adtalem Global Education (NYSE:ATGE) exceeded Q4 CY2025 revenue expectations and reported non-GAAP profit above analyst consensus, driven by sustained enrollment growth and digital investments. The company raised its full-year Adjusted EPS guidance and highlighted strong performances at Walden University and Chamberlain. Future performance is expected to be fueled by continued enrollment trends, digital program expansion, and strategic partnerships like the one with Sallie Mae.
Adtalem Global Education Inc. (NYSE:ATGE) Q2 2026 Earnings Call Transcript
Adtalem Global Education Inc. (NYSE: ATGE) reported its Q2 2026 earnings, with an actual EPS of $2.11, missing the $2.19 expectation. The company highlighted its tenth consecutive quarter of enrollment growth, driven by strong performance at Walden, and confirmed its full-year revenue guidance while raising its adjusted EPS guidance to 17% to 20% growth. Despite a temporary slowdown in Chamberlain's enrollment, Adtalem is confident in its recovery strategy and overall growth trajectory, emphasizing its role in addressing the healthcare workforce shortage.
Why Adtalem (ATGE) Stock Is Nosediving
Adtalem Global Education (ATGE) shares dropped 9.5% after the company reported mixed fourth-quarter 2025 results. Despite beating revenue and adjusted EPS expectations, a significant miss on adjusted EBITDA sparked investor concern regarding underlying profitability. The stock's performance indicates the market views this news as meaningful but not fundamentally altering its perception of the business.
Adtalem Global Education Q2 Earnings Call Highlights
Adtalem Global Education (NYSE: ATGE) reported strong fiscal Q2 2026 results, with total enrollment up over 6% and revenue increasing by 12% to $503 million. The company raised its adjusted EPS guidance for the full year to $7.80–$8.00, driven by significant growth at Walden University and effective capital allocation including share repurchases. Despite a temporary soft period for Chamberlain, management expressed confidence in addressing enrollment gaps and highlighted positive trends in its Medical and Veterinary segment.
Teacher Retirement System of Texas Sells 52,260 Shares of Adtalem Global Education Inc. $ATGE
The Teacher Retirement System of Texas significantly reduced its stake in Adtalem Global Education Inc. (NYSE:ATGE) by selling 52,260 shares, now owning 18,474 shares valued at $2.85 million. This divestment comes amidst mixed signals for ATGE, including a beat on Q2 earnings estimates and raised fiscal-2026 EPS guidance, but also concerns about cash flow and liquidity. Institutional investors collectively own 98.84% of the company, and analysts have a "Moderate Buy" rating with a consensus target price of $156.50.
Adtalem (NYSE:ATGE) Posts Better-Than-Expected Sales In Q4 CY2025
Adtalem Global Education (NYSE:ATGE) reported better-than-expected Q4 CY2025 results, with sales up 12.4% year-on-year to $503.4 million, exceeding market estimates. The company's non-GAAP profit of $2.43 per share was also above analysts' consensus, and management raised its full-year Adjusted EPS guidance. Despite strong revenue and EPS beats, adjusted EBITDA missed expectations.
Adtalem Global Education Q2 FY 2026 Results
Adtalem Global Education (ATGE) reported strong Q2 FY 2026 financial results, with significant revenue and adjusted EPS growth, driven by its "Growth with Purpose" strategy. The company achieved its tenth consecutive quarter of student enrollment growth, reaching 97,010 students, and successfully executed share repurchase programs. Adtalem also provided optimistic guidance for fiscal year 2026, projecting continued revenue and adjusted EPS growth.
Earnings call transcript: Adtalem Global Education beats expectations in Q2 2026
Adtalem Global Education reported strong Q2 2026 results, exceeding revenue and adjusted EPS expectations with $503.4 million and $2.43 respectively, driven by enrollment growth and healthcare education focus. Despite the positive financial performance, the stock experienced a slight decline in after-hours trading. The company raised its full-year adjusted EPS guidance, demonstrating confidence in its strategic initiatives and market position as a leading healthcare educator.
Adtalem: Fiscal Q2 Earnings Snapshot
Adtalem Global Education Inc. (ATGE) reported a fiscal second-quarter net income of $76.4 million, translating to $2.11 per share. Adjusted earnings were $2.43 per share, with the company recording $503.4 million in revenue. Adtalem shares have seen a 12% increase since the start of the year and an 18% increase over the last 12 months.
Adtalem Global Education Inc. SEC 10-Q Report
Adtalem Global Education Inc. has released its latest 10-Q report, detailing strong financial and operational performance for the period ended December 31, 2025. The report highlights significant revenue growth, improved profitability, and robust operational metrics across its educational segments, including Chamberlain University, Walden University, and the Medical and Veterinary Segment. The company plans to continue expanding its offerings and maintaining leadership in healthcare education.
Adtalem Global Education (NYSE:ATGE) Announces Earnings Results, Beats Expectations By $0.24 EPS
Adtalem Global Education (NYSE:ATGE) reported earnings results, with Q4 EPS of $2.43, beating the consensus estimate by $0.24, and revenue of $503.39 million, exceeding expectations. The company's shares traded up 0.7% to $115.98, and it maintains a "Moderate Buy" consensus rating from analysts with an average price target of $156.50. The article also highlights recent insider purchases by directors and significant institutional ownership.
Adtalem Global Education Second Quarter Fiscal Year 2026 Results; Raises Fiscal Year 2026 Adjusted Earnings Per Share Guidance
Adtalem Global Education reported strong second-quarter fiscal year 2026 results, showing a 6.3% year-over-year increase in total enrollment and a 12.4% rise in revenue. The company also announced a new $750 million share repurchase program and raised its fiscal year 2026 adjusted earnings per share guidance, reflecting confidence in its "Growth with Purpose" strategy and financial performance.
Adtalem Global Education Inc. $ATGE Shares Sold by Trek Financial LLC
Trek Financial LLC significantly reduced its stake in Adtalem Global Education Inc. ($ATGE) by 88.7% in Q3, selling 31,448 shares and retaining 4,020 shares worth $621,000. This comes as other institutions like Goldman Sachs increased their positions, and institutional ownership stands at 98.84%. Adtalem also reported strong Q3 earnings, beating estimates with $1.75 EPS and revenues of $462.3M, and analysts maintain a "Moderate Buy" rating with a target price of $156.50.
Adtalem (ATGE) Reports Q4: Everything You Need To Know Ahead Of Earnings
Adtalem Global Education (ATGE) is set to report its Q4 earnings after market hours this Wednesday. Analysts expect revenue to grow 9.6% year-on-year to $490.6 million and adjusted earnings of $2.19 per share. The company has consistently beaten revenue estimates in the past two years, and analysts have reconfirmed their estimates ahead of the announcement.
Adtalem Global Education Inc. $ATGE Stock Position Decreased by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Adtalem Global Education Inc. by 12.0% in Q3, selling 12,194 shares and retaining 89,703 shares valued at $13.86 million. Despite this, Adtalem reported strong Q3 earnings, beating EPS expectations with $1.75 and achieving revenue of $462.29 million, leading to a "Moderate Buy" consensus rating from analysts with an average target price of $156.50. Insider activity showed directors making modest share purchases, and the company provided positive FY2026 guidance.
Possible Bearish Signals With Adtalem Global Education Insiders Disposing Stock
Over the past year, Adtalem Global Education (NYSE: ATGE) insiders sold a significant amount of stock, totaling US$9.6 million, compared to US$229k in purchases. While a recent purchase by two insiders suggests some confidence, the overall selling trend, especially the large sale by Director Lisa Wardell at a price close to current levels, could be a cautionary sign for shareholders. Despite this, insiders still own a notable 2.4% of the company, indicating some alignment with long-term interests.
